← FDA Drug Approvals (Drugs@FDA)

LASMIDITAN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: QILU PHARMACEUTICAL CO., LTD. · Approved 2024-12-20

Drug application

FDA Application #

ANDA219350

Application type

Abbreviated New Drug Application (Generic)

Brand name

LASMIDITAN

Generic name

Lasmiditan

Active ingredients

LASMIDITAN

Dosage form

TABLET

Route

—

Marketing status

None (Tentative Approval)

Sponsor

QILU PHARMACEUTICAL CO., LTD.

First approval

2024-12-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown